Autolus Therapeutics plc (AUTL)
NASDAQ·Healthcare·Biotechnology
$1.48
+3.87%
Mkt Cap $431.15M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $23.92M | $24.29M | +1.56% | -$0.26 | -$0.34 | -30.80% | — | — |
| Q4 2025 Nov 12, 2025 | $24.41M | $21.19M | -13.16% | -$0.23 | -$0.30 | -30.43% | — | — |
| Q3 2025 Aug 12, 2025 | $21.08M | $20.92M | -0.74% | -$0.24 | -$0.18 | +25.00% | — | — |
| Q2 2025 May 8, 2025 | $2.20M | $8.98M | +309.13% | -$0.24 | -$0.26 | -8.33% | — | — |
| Q1 2025 Mar 20, 2025 | $1.52M | $29.00K | -98.09% | -$0.21 | -$0.09 | +57.14% | — | — |
| Q4 2024 Nov 12, 2024 | $387.29K | — | — | -$0.21 | -$0.31 | -47.62% | — | — |
| Q3 2024 Aug 8, 2024 | $130.00K | — | — | -$0.19 | -$0.22 | -15.79% | — | — |
| Q2 2024 May 17, 2024 | $10.00M | $10.09M | +0.91% | -$0.10 | -$0.24 | -140.00% | — | — |
| Q1 2024 Mar 14, 2024 | $360.00K | $1.77M | +393.06% | -$0.26 | -$0.44 | -69.23% | — | — |
| Q4 2023 Nov 2, 2023 | $300.00K | $406.00K | +35.33% | -$0.24 | -$0.26 | -8.33% | — | — |
| Q3 2023 Aug 3, 2023 | $390.00K | — | — | -$0.22 | -$0.26 | -18.18% | — | — |
| Q2 2023 May 4, 2023 | $140.00K | $1.29M | +822.86% | -$0.28 | -$0.23 | +17.86% | — | — |
| Q1 2023 Mar 7, 2023 | $350.00K | $3.83M | +992.86% | -$0.31 | -$0.23 | +25.81% | — | — |
| Q4 2022 Nov 3, 2022 | $144.29K | $2.37M | +1541.88% | -$0.46 | -$0.47 | -2.17% | — | — |
| Q3 2022 Aug 4, 2022 | $240.56K | — | — | -$0.42 | -$0.46 | -9.52% | — | — |
| Q2 2022 May 5, 2022 | $171.43K | $166.00K | -3.17% | -$0.51 | -$0.41 | +19.61% | — | — |
| Q1 2022 Mar 10, 2022 | $854.78K | $823.00K | -3.72% | -$0.49 | -$0.51 | -4.08% | — | — |
| Q4 2021 Nov 3, 2021 | $250.00K | $236.00K | -5.60% | -$0.50 | -$0.47 | +6.00% | — | — |
| Q3 2021 Aug 5, 2021 | $1.65M | $1.51M | -8.39% | -$0.50 | -$0.47 | +6.00% | — | — |
| Q2 2021 May 6, 2021 | $300.38K | $269.00K | -10.45% | -$0.62 | -$0.53 | +14.52% | — | — |